7-147559018-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1778-3120G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.226 in 152,128 control chromosomes in the GnomAD database, including 4,677 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4677 hom., cov: 33)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.551

Publications

2 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.302 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1778-3120G>A intron_variant Intron 11 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.1778-3120G>A intron_variant Intron 11 of 13 XP_016867439.1
LOC107986721XR_001744999.2 linkn.142-397C>T intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1778-3120G>A intron_variant Intron 11 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000636870.1 linkn.1640-3120G>A intron_variant Intron 9 of 21 5
CNTNAP2ENST00000637825.1 linkn.1261-3120G>A intron_variant Intron 8 of 13 5
CNTNAP2ENST00000638117.1 linkn.1681-3120G>A intron_variant Intron 10 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34415
AN:
152010
Hom.:
4673
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0746
Gnomad AMI
AF:
0.436
Gnomad AMR
AF:
0.194
Gnomad ASJ
AF:
0.310
Gnomad EAS
AF:
0.246
Gnomad SAS
AF:
0.303
Gnomad FIN
AF:
0.268
Gnomad MID
AF:
0.268
Gnomad NFE
AF:
0.305
Gnomad OTH
AF:
0.237
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.226
AC:
34427
AN:
152128
Hom.:
4677
Cov.:
33
AF XY:
0.223
AC XY:
16591
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0746
AC:
3098
AN:
41524
American (AMR)
AF:
0.194
AC:
2967
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.310
AC:
1077
AN:
3472
East Asian (EAS)
AF:
0.247
AC:
1271
AN:
5154
South Asian (SAS)
AF:
0.304
AC:
1466
AN:
4824
European-Finnish (FIN)
AF:
0.268
AC:
2831
AN:
10572
Middle Eastern (MID)
AF:
0.257
AC:
75
AN:
292
European-Non Finnish (NFE)
AF:
0.305
AC:
20741
AN:
68000
Other (OTH)
AF:
0.241
AC:
507
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1355
2710
4065
5420
6775
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.242
Hom.:
624
Bravo
AF:
0.212
Asia WGS
AF:
0.251
AC:
872
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.9
DANN
Benign
0.24
PhyloP100
0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13225016; hg19: chr7-147256110; API